*Cincinnati Eye Institute, University of Cincinnati, Cincinnati, OH;
†Virginia Eye Consultants, Norfolk, VA;
‡Department of Medicine, Surgery, and Neuroscience, University of Siena, Siena, Italy;
§Division of Nephrology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; and
¶Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH.
Correspondence: Edward J. Holland, MD, 580 South Loop Rd, Suite 200, Edgewood, KY 41017 (e-mail: [email protected]).
E. J. Holland has consulted for Alcon Laboratories, Allergan, Bausch & Lomb, Kala Pharmaceuticals, Mati Pharmaceuticals, Omeros, PRN, Senju Pharmaceuticals, Shire, TearLab, and TearScience. A. Y. Cheung has a grant from the Eye Bank Association of America and has consulted for Alcon. The other authors have no funding or conflicts of interest to disclose.
